目的分析SH3BP2基因点突变后,与其相关的信号转导通路发生的变化,探讨巨颌症发病的分子机制。方法采用免疫荧光技术检测巨颌症患者的活化T细胞核因子(nuclear factor of activated Tcells,NFAT)家族中的NFATc1及SH3BP2蛋白在细胞内的定...目的分析SH3BP2基因点突变后,与其相关的信号转导通路发生的变化,探讨巨颌症发病的分子机制。方法采用免疫荧光技术检测巨颌症患者的活化T细胞核因子(nuclear factor of activated Tcells,NFAT)家族中的NFATc1及SH3BP2蛋白在细胞内的定位及表达含量的变化。结果巨颌症标本中NFATc1总体表达含量变化不明显,但发生了核内转位;SH3BP2在巨颌症组织中表达量增高。结论巨颌症致病基因SH3BP2发生点突变后,SH3BP2蛋白表达量可增多,并可导致NFATc1发生核内转位,这可能是导致巨颌症病变中破骨细胞被激活,形成骨吸收的重要机制。展开更多
目的探讨基因预测软件Targetscan预测到的微小RNA-130a如何调节GTP酶激活蛋白SH3功能区结合蛋白2(GTPase activating protein SH3 binding protein 2,G3BP2)的表达,进而影响乳腺癌细胞的侵袭。方法应用实时荧光定量PCR(qRT-PCR)检测正...目的探讨基因预测软件Targetscan预测到的微小RNA-130a如何调节GTP酶激活蛋白SH3功能区结合蛋白2(GTPase activating protein SH3 binding protein 2,G3BP2)的表达,进而影响乳腺癌细胞的侵袭。方法应用实时荧光定量PCR(qRT-PCR)检测正常乳腺上皮及乳腺癌细胞系中miR-130a的表达水平;蛋白质印迹法(Western blot)检测改变miR-130a表达水平对乳腺癌细胞株MCF-7和MDA-MB-231中G3BP2及上皮间质转化(epithelial-to-mesenchymal transition,EMT)相关蛋白的影响;双荧光素酶报告基因实验检测miR-130a是否能与G3BP2靶向结合,以及Transwell侵袭实验检测miR-130a表达水平与MCF-7和MDA-MB-231细胞侵袭能力的关系。结果qRT-PCR显示miR-130a表达量在高侵袭乳腺癌细胞株明显高于低侵袭乳腺癌细胞株MCF-7及正常乳腺上皮细胞;Western blot检测显示,miR-130a负向调控G3BP2的表达并促进乳腺癌细胞发生EMT;qRT-PCR显示改变乳腺癌细胞内miR-130a表达后G3BP2 mRNA基本没有变化;双荧光素酶报告基因结果显示,miR-130a能与G3BP2 mRNA的3’UTR结合;Transwell侵袭实验显示,miR-130a促进乳腺癌细胞的体外侵袭。结论miR-130a通过靶向结合G3BP2 mRNA的3’UTR区,在翻译水平抑制G3BP2表达后促进乳腺癌细胞发生EMT,从而促进乳腺癌细胞的侵袭。展开更多
Background:Long non-codingRNAs(lncRNAs)have been found to be involved in the development of many cancers.In this study,we aimed to identify the molecular mechanisms of lncRNA BAALC antisense RNA 1(BAALC-AS1)in regulat...Background:Long non-codingRNAs(lncRNAs)have been found to be involved in the development of many cancers.In this study,we aimed to identify the molecular mechanisms of lncRNA BAALC antisense RNA 1(BAALC-AS1)in regulating the malignancy of esophageal squamous cell carcinoma(ESCC).Methods:The expression of BAALC-AS1 in cancer patients was analyzed using a tissue microarray.The protein and RNA levels of BAALC-AS1 were determined by Western blotting analysis and quantitative reverse transcription-PCR(RT-qPCR),respectively.The cell proliferation was determined by cell viability assays,bromodeoxyuridine incorporation,and flow cytometry.The relationships among BAALC-AS1,RasGAPSH3 domain-binding protein 2(G3BP2),and c-Myc were determined using RNA immunoprecipitation,RNA pull-down assays,and luciferase assays.Results:The expression of BAALC-AS1 was highly up-regulated and associated with malignant phenotypes in ESCC tissues and cell lines.In vivo and in vitro assays showed that BAALC-AS1 promoted ESCC cell proliferation,migration,and invasion.BAALC-AS1 directly interacted with G3BP2,and thereby inhibited the degradation of c-Myc RNA 3’-UTR by G3BP2,thus leading to the accumulation of c-Myc expression.Additionally,c-Myc acted as a transcription factor that can induce the expression of BAALC-AS1 by directly binding to its promoter region.Conclusions:BAALC-AS1/G3BP2/c-Myc feedback loop plays a critical role in the development of ESCC,which might provide a novel therapeutic target and facilitate the development of new therapeutic strategies for the treatment of ESCC.展开更多
GTPase-activating SH3 domain-binding protein 2(G3BP2)is a mediator that responds to environmental stresses through stress granule formation and is involved in the progression of chronic diseases.However,no studies hav...GTPase-activating SH3 domain-binding protein 2(G3BP2)is a mediator that responds to environmental stresses through stress granule formation and is involved in the progression of chronic diseases.However,no studies have examined the contribution of G3BP2 in the oscillatory shear stress(OSS)-induced endothelial dysfunction.Here we assessed the effects of G3BP2 in endothelial cells(ECs)function and investigated the underlying mechanism.Using shear stress apparatus and partial ligation model,we identified that stress granulerelated genes in ECs could be induced by OSS with RNA-seq,and then confirmed that G3BP2 was highly and specifically expressed in athero-susceptible endothelia in the OSS regions.G3bp2e/eApoee/e mice had significantly decreased atherosclerotic lesions associated with deficiency of G3BP2 in protecting endothelial barrier function,decreasing monocyte adhesion to ECs and inhibiting the proinflammatory cytokine levels.Furthermore,loss of G3BP2 diminished OSS-induced inflammation in ECs by increasing YAP nucleocytoplasmic shuttling and phosphorylation.These data demonstrate that G3BP2 is a critical OSS regulated gene in regulating ECs function and that G3BP2 inhibition in ECs is a promising atheroprotective therapeutic strategy.展开更多
Numerous studies have characterized the critical role of circular RNAs(circRNAs)as regulatory factors in the progression of multiple cancers.However,the biological functions of circRNAs and their underlying molecular ...Numerous studies have characterized the critical role of circular RNAs(circRNAs)as regulatory factors in the progression of multiple cancers.However,the biological functions of circRNAs and their underlying molecular mechanisms in the progression of uveal melanoma(UM)remain enigmatic.In this study,we identified a novel circRNA,circ_0053943,through re-analysis of UM microarray data and quantitative RT-PCR.Circ_0053943 was found to be upregulated in UM and to promote the proliferation and metastatic ability of UM cells in both in vitro and in vivo settings.Mechanistically,circ_0053943 was observed to bind to the KH1 and KH2 domains of insulin-like growth factor 2 mRNA-binding protein 3(IGF2BP3),thereby enhancing the function of IGF2BP3 by stabilizing its target mRNA.RNA sequencing assays identified epidermal growth factor receptor(EGFR)as a target gene of circ_0053943 and IGF2BP3 at the transcriptional level.Rescue assays demonstrated that circ_0053943 exerts its biological function by stabilizing EGFR mRNA and regulating the downstream mitogen-activated protein kinase/extracellular signal-regulated kinase(MAPK/ERK)signaling pathway.Collectively,circ_0053943 may promote UM progression by stabilizing EGFR mRNA and activating the MAPK/ERK signaling pathway through the formation of a circ_0053943/IGF2BP3/EGFR RNA-protein ternary complex,thus providing a potential biomarker and therapeutic target for UM.展开更多
文摘目的分析SH3BP2基因点突变后,与其相关的信号转导通路发生的变化,探讨巨颌症发病的分子机制。方法采用免疫荧光技术检测巨颌症患者的活化T细胞核因子(nuclear factor of activated Tcells,NFAT)家族中的NFATc1及SH3BP2蛋白在细胞内的定位及表达含量的变化。结果巨颌症标本中NFATc1总体表达含量变化不明显,但发生了核内转位;SH3BP2在巨颌症组织中表达量增高。结论巨颌症致病基因SH3BP2发生点突变后,SH3BP2蛋白表达量可增多,并可导致NFATc1发生核内转位,这可能是导致巨颌症病变中破骨细胞被激活,形成骨吸收的重要机制。
基金supported by the National Natural Science Foundation of China(81830086,81988101,81702748,and 81902835)China Postdoctoral Science Foundation(2020M670067)+1 种基金Beijing Municipal Commission of Health and Family Planning Project(PXM2018_026279_000005)Guangdong Basic and Applied Basic Research Foundation(2019B030302012).
文摘Background:Long non-codingRNAs(lncRNAs)have been found to be involved in the development of many cancers.In this study,we aimed to identify the molecular mechanisms of lncRNA BAALC antisense RNA 1(BAALC-AS1)in regulating the malignancy of esophageal squamous cell carcinoma(ESCC).Methods:The expression of BAALC-AS1 in cancer patients was analyzed using a tissue microarray.The protein and RNA levels of BAALC-AS1 were determined by Western blotting analysis and quantitative reverse transcription-PCR(RT-qPCR),respectively.The cell proliferation was determined by cell viability assays,bromodeoxyuridine incorporation,and flow cytometry.The relationships among BAALC-AS1,RasGAPSH3 domain-binding protein 2(G3BP2),and c-Myc were determined using RNA immunoprecipitation,RNA pull-down assays,and luciferase assays.Results:The expression of BAALC-AS1 was highly up-regulated and associated with malignant phenotypes in ESCC tissues and cell lines.In vivo and in vitro assays showed that BAALC-AS1 promoted ESCC cell proliferation,migration,and invasion.BAALC-AS1 directly interacted with G3BP2,and thereby inhibited the degradation of c-Myc RNA 3’-UTR by G3BP2,thus leading to the accumulation of c-Myc expression.Additionally,c-Myc acted as a transcription factor that can induce the expression of BAALC-AS1 by directly binding to its promoter region.Conclusions:BAALC-AS1/G3BP2/c-Myc feedback loop plays a critical role in the development of ESCC,which might provide a novel therapeutic target and facilitate the development of new therapeutic strategies for the treatment of ESCC.
基金This work was supported by the National Natural Science FoundationofChina(No.31971242 and12032007 toG.W.)The Natural Science Foundation of Chongqing,China(No.cstc2019jcyj-zdxmX0028 to G.W.,cstc2019jcyj-xfkxX0004 to J.Q.)+2 种基金Open Fund of Tianjin Enterprise Key Laboratory on Hyaluronic Acid Application Research,China(No.KTRDHAY201903 to G.W.)The Fundamental Research Funds for the Central Universities,China(No.2019CDYGZD008 to J.Q.)Chongqing Municipal Education Commission,China(No.KYYJ202001 to G.W.).
文摘GTPase-activating SH3 domain-binding protein 2(G3BP2)is a mediator that responds to environmental stresses through stress granule formation and is involved in the progression of chronic diseases.However,no studies have examined the contribution of G3BP2 in the oscillatory shear stress(OSS)-induced endothelial dysfunction.Here we assessed the effects of G3BP2 in endothelial cells(ECs)function and investigated the underlying mechanism.Using shear stress apparatus and partial ligation model,we identified that stress granulerelated genes in ECs could be induced by OSS with RNA-seq,and then confirmed that G3BP2 was highly and specifically expressed in athero-susceptible endothelia in the OSS regions.G3bp2e/eApoee/e mice had significantly decreased atherosclerotic lesions associated with deficiency of G3BP2 in protecting endothelial barrier function,decreasing monocyte adhesion to ECs and inhibiting the proinflammatory cytokine levels.Furthermore,loss of G3BP2 diminished OSS-induced inflammation in ECs by increasing YAP nucleocytoplasmic shuttling and phosphorylation.These data demonstrate that G3BP2 is a critical OSS regulated gene in regulating ECs function and that G3BP2 inhibition in ECs is a promising atheroprotective therapeutic strategy.
基金国家自然科学基金(82270162,82270224,82070178)北京市自然科学基金(7222175)+2 种基金军队卫勤保障能力创新与生成专项(21WQ034)保健专项科研课题重点项目(21BJZ30)国家重点研发计划(2021Y FA 1100904)。
文摘目的:探寻IGF2BP3基因表达水平与急性髓系白血病(AML)患者预后的关系。方法:通过对本中心27例AML患者骨髓原代白血病细胞进行转录组高通量测序,分析IGF2BP3基因表达水平与患者临床特征之间的关系,并在初治AML患者及难治AML(Refractory AML)患者样本中验证。分析20例健康对照者和26例AML患者中IGF2BP3基因表达水平的差异。采用RT-qPCR、Western blot检测两种蒽环类耐药细胞系(HL60/ADR、K562/ADR)中IGF2BP3表达水平,比较其与敏感细胞(HL60、K562)的表达差异。通过3个数据集,分析IGF2BP3在AML患者中的表达水平及与预后的关系,进一步使用Cox生存分析IGF2BP3在AML中的预后价值。结果:在本中心27例AML患者骨髓原代白血病细胞中,难治性AML患者的IGF2BP3表达量明显高于化疗敏感的患者(P=0.0343),白血病细胞髓外浸润(extramedullary infiltration,EMI)患者的IGF2BP3表达量明显高于无髓外浸润的AML患者(P=0.0049)。与健康人比较,IGF2BP3在AML患者中表达增加(P=0.0009)。蒽环类耐药细胞系(HL60/ADR、K562/ADR)中IGF2BP3 mRNA的表达显著高于敏感细胞系(K562/ADR vs K562,P=0.0430;HL60/ADR vs HL60,P=0.7369)。Western blot结果显示,耐药细胞中IGF2BP3蛋白表达显著高于敏感细胞(P<0.001)。qPCR结果显示,难治AML患者中IGF2BP3的mRNA表达水平明显高于化疗敏感患者(P=0.002)。在3个大样本AML患者队列中IGF2BP3高表达预示AML预后不良(P<0.05)。单因素和多因素预后分析证实IGF2BP3高表达与患者较短的无事件生存(HR=1.887,P=0.024)和总体生存(HR=1.619,P=0.016)显著相关。结论:IGF2BP3基因高表达可能是AML预后不良的重要因素,提示IGF2BP3基因有望成为AML的临床预后评估和提供治疗策略的新的分子标志物。
基金supported by the National Natural Science Foundation of China(Nos.82273159 and 82171838)the Jiangsu Province’s Science and Technology Project(No.BE2020722).
文摘Numerous studies have characterized the critical role of circular RNAs(circRNAs)as regulatory factors in the progression of multiple cancers.However,the biological functions of circRNAs and their underlying molecular mechanisms in the progression of uveal melanoma(UM)remain enigmatic.In this study,we identified a novel circRNA,circ_0053943,through re-analysis of UM microarray data and quantitative RT-PCR.Circ_0053943 was found to be upregulated in UM and to promote the proliferation and metastatic ability of UM cells in both in vitro and in vivo settings.Mechanistically,circ_0053943 was observed to bind to the KH1 and KH2 domains of insulin-like growth factor 2 mRNA-binding protein 3(IGF2BP3),thereby enhancing the function of IGF2BP3 by stabilizing its target mRNA.RNA sequencing assays identified epidermal growth factor receptor(EGFR)as a target gene of circ_0053943 and IGF2BP3 at the transcriptional level.Rescue assays demonstrated that circ_0053943 exerts its biological function by stabilizing EGFR mRNA and regulating the downstream mitogen-activated protein kinase/extracellular signal-regulated kinase(MAPK/ERK)signaling pathway.Collectively,circ_0053943 may promote UM progression by stabilizing EGFR mRNA and activating the MAPK/ERK signaling pathway through the formation of a circ_0053943/IGF2BP3/EGFR RNA-protein ternary complex,thus providing a potential biomarker and therapeutic target for UM.
